Detalles de la búsqueda
1.
Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models.
J Hepatol
; 75(6): 1335-1345, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363922
2.
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
J Med Virol
; 92(2): 210-218, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31584207
3.
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
J Gen Virol
; 100(7): 1123-1131, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31199224
4.
Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure.
J Gen Virol
; 99(8): 1058-1065, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29916799
5.
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice.
Biochem Biophys Res Commun
; 500(2): 152-157, 2018 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29621544
6.
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.
Hepatol Res
; 48(2): 193-204, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544062
7.
Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinoma.
Hepatol Res
; 48(13): 1118-1130, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30030881
8.
Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.
J Med Virol
; 89(12): 2144-2148, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28667756
9.
Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy.
Clin J Gastroenterol
; 13(2): 267-270, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31463795
10.
Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusion.
Nat Microbiol
; 5(12): 1532-1541, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868923
11.
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
Ther Adv Med Oncol
; 12: 1758835920922051, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32547646
12.
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.
J Clin Invest
; 130(6): 3205-3220, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32163375
13.
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.
J Gastroenterol
; 54(3): 291-296, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30334096
14.
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.
Hepatol Commun
; 3(3): 348-355, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859147
15.
Cholangiolocellular Carcinoma in a Young Patient Who Showed Sustained Virological Response after Treatment for Hepatitis C Virus Infection.
Intern Med
; 56(22): 3033-3040, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28943584
Resultados
1 -
15
de 15
1
Próxima >
>>